Peripheral Neuropathy Associated with Fluoroquinolones

  title={Peripheral Neuropathy Associated with Fluoroquinolones},
  author={Jay S. Cohen},
  journal={Annals of Pharmacotherapy},
  pages={1540 - 1547}
  • Jay S. Cohen
  • Published 1 December 2001
  • Medicine
  • Annals of Pharmacotherapy
OBJECTIVE: To survey cases of fluoroquinolone-associated adverse events that included peripheral nervous system (PNS) symptoms posted on Internet Web sites. METHODS: Cases were obtained with the assistance of members of Web sites formed by people sustaining fluoroquinolone-related events. Information obtained met the standards of MedWatch, and each reported case was assessed using the Naranjo probability scale. RESULTS: In contrast to previous reports suggesting that fluoroquinolone-associated… 

Tables from this paper

Oral fluoroquinolone use and risk of peripheral neuropathy
Current users, especially new users of FQs, are at a higher risk of developing PN, and clinicians should weigh the benefits against the risk of adverse events when prescribing these drugs to their patients.
Comment: Peripheral Neuropathy Syndrome and Fluoroquinolones
The present study attempts to document a significant link between PNS and fluoroquinolone use by using a sample of potentially biased patients using the Internet to identify cases and facing a few problems related to the study design.
Intractable Acute Pain Related to Fluoroquinolone-Induced Peripheral Neuropathy
The patient is a 20-year-old male, with well-controlled type 1 diabetes mellitus, presenting with a short duration of bilateral lower extremity pain following a 10-day course of levofloxacin for suspected epididymitis.
Linezolid-Associated Peripheral and Optic Neuropathy in Children
While linezolid may be used to treat serious infections often needing extended courses of therapy, potential safety concerns should be kept in mind.
A VigiBase Descriptive Study of Fluoroquinolone-Associated Peripheral Nervous System Disorders
The results augment the existing data on FQ safety concerns, specifically their potential effect on the nervous system, as well as potential risk factors, such as associated therapy and underlying disease.
Do Fluoroquinolones Cause Neuropathy
FDA recommends that patients with symptoms of peripheral neuropathy after taking systemic fluoroquinolone to stop the medication and to be treated with an alternative non-fluoroquolone antibacterial drug.
Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
Physicians and patients should be alert to the potential for FQ-induced severe disabling multisymptom pathology that may persist and progress following FQ use.
Quinolones: review of psychiatric and neurological adverse reactions.
The aim of this article was to review the neurological and psychiatric adverse drug reaction (ADR) profile of quinolones, using a literature search strategy designed to identify case reports and case series related to quInolone-associated neurological and Psychiatric ADRs.
Adverse Effects of Fluoroquinolones: A Retrospective Cohort Study in a South Indian Tertiary Healthcare Facility
A harmful association between FQ use and the development of ADRs is concluded, and FQs are not safe compared to other antibiotics, Hence, the use of F Qs should be limited to the conditions where no other alternatives are available.


Peripheral sensory disturbances related to treatment with fluoroquinolones.
The symptoms and possible risk factors of peripheral sensory disturbances related to fluoroquinolones are reviewed on the basis of 37 reports submitted to the Swedish Adverse Drug Reactions Advisory
The safety profile of the fluoroquinolones.
Fluoroquinolone toxicity profiles: a review focusing on newer agents.
  • Benjamin A Lipsky, C. Baker
  • Biology, Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 1999
Fluoroquinolones are safe in elderly, human immunodeficiency virus-infected, and neutropenic patients, but because of possible effects on articular cartilage, they are not currently recommended for children or pregnant women.
Clinical experience with pefloxacin in patients with urinary tract infections.
The overall bacteriological cure rate at four to eight weeks was 87.5% (21/24), and the incidence of possible side-effects was high, occurring in 59% of the patients, and Nausea, dizziness and vomiting were the most common.
Potential Interactions of the Extended-Spectrum Fluoroquinolones with the CNS
  • H. Lode
  • Biology, Medicine
    Drug safety
  • 1999
Ongoing and future clinical studies will help to define the usefulness of the predictive models, as well as reveal the full CNS adverse event profile of these and other investigational fluoroquinolones.
Neurologic Adverse Effects during Concomitant Treatment with Ciprofloxacin, Nsaids, and Chloroquine: Possible Drug Interaction
A 68-year-old woman who was receiving chronic treatment with NSAIDs and chloroquine developed dizziness, anxiety, and tremors when ciprofloxacin 500 mg twice daily was begun for Salmonella osteitis and when she discontinued the antirheumatic treatment, there was a prompt relief of symptoms.
Potential Neurologic Toxicity Related to Ciprofloxacin
Seizure activity has been reported to occur with the quinolone antibiotics and, with the increasing use of these agents, dose reductions should be kept in mind to avoid potentially serious adverse reactions.
Prevention and Management of Drug-Induced Peripheral Neuropathy
While waiting for recovery physiotherapy is of importance, and when paraesthesia and pain are troublesome the patient should be treated with carbamazepine, imipramine or lidocaine (lignocaine).
Fluoroquinolone toxicities. An update.
The main types of adverse effects associated with quinolones are uncommon and reversible and vary in frequency among different agents, while fluoroquinolones as a group are effective and very well tolerated antimicrobial drugs.